Neurotoxicity of MDMA: Main effects and mechanisms.
Costa G, Gołembiowska K.
Exp Neurol. 2022 Jan;347:113894. doi: 10.1016/j.expneurol.2021.113894. Epub 2021 Oct 13.
[Hallucinogenic mushrooms].
Reingardiene D, Vilcinskaite J, Lazauskas R.
Medicina (Kaunas). 2005;41(12):1067-70.
Hallucinogen Use Disorders.
Hardaway R, Schweitzer J, Suzuki J.
Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):489-96. doi: 10.1016/j.chc.2016.03.006. Epub 2016 Apr 18.
[Hallucinogen-induced psychological disorders].
Hermle L, Kovar KA, Hewer W, Ruchsow M.
Fortschr Neurol Psychiatr. 2008 Jun;76(6):334-42. doi: 10.1055/s-2008-1038191.
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis.
Hindley G, Beck K, Borgan F, Ginestet CE, McCutcheon R, Kleinloog D, Ganesh S, Radhakrishnan R, D'Souza DC, Howes OD.
Lancet Psychiatry. 2020 Apr;7(4):344-353. doi: 10.1016/S2215-0366(20)30074-2. Epub 2020 Mar 17.
Is LSD toxic?
Nichols DE, Grob CS.
Forensic Sci Int. 2018 Mar;284:141-145. doi: 10.1016/j.forsciint.2018.01.006. Epub 2018 Feb 2.
Bath salts.
Gerona RR, Wu AH.
Clin Lab Med. 2012 Sep;32(3):415-27. doi: 10.1016/j.cll.2012.07.010.
[Medication-induced psychoses].
Senon JL, Lafay N, Padet N.
Encephale. 2003 Sep;29(Pt 2):S8-11.
[Phencyclidine--angel dust].
Høiseth G, Hjelmeland K, Bachs L.
Tidsskr Nor Laegeforen. 2005 Oct 20;125(20):2775-6.
The impact of cannabis legalization and decriminalization on acute poisoning: A systematic review.
Allaf S, Lim JS, Buckley NA, Cairns R.
Addiction. 2023 Dec;118(12):2252-2274. doi: 10.1111/add.16280. Epub 2023 Jul 26.
